<DOC>
	<DOCNO>NCT01051024</DOCNO>
	<brief_summary>The purpose study assess efficacy Diamel administration treatment Polycystic Ovary Syndrome . The duration double-blind placebo control phase 3 clinical trial 24 week .</brief_summary>
	<brief_title>Diamel Treatment Polycystic Ovary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>Two follow criterion : Oligo Anovulation Polycystic Ovary diagnose ultrasound technique Clinical sign Hyperandrogenism Signed inform consent Personal history cause hyperandrogenism : Hyperprolactinemia , suprarenal tumor , ovary tumor , suprarenal hyperplasia , hypercortisolism . Patients experimental treatment Treatment ovulation inducer and/or insulin sensitizer within 60 day treatment Treatment vitamin within 7 day treatment Treatment dietary supplement within 60 day treatment Noncompensated intercurrent disease : diabetes mellitus , thyroid disease , hypertension</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Dietary supplement</keyword>
	<keyword>Diamel</keyword>
	<keyword>Polycystic Ovary Syndrome</keyword>
	<keyword>Female Infertility</keyword>
</DOC>